Lilly(LLY)2025-02-06 12:05Earnings and Revenue Guidance - Eli Lilly and Company will provide an update on 2024 earnings guidance and share its 2025 revenue guidance range during the 2025 J.P. Morgan Healthcare Conference[5] Market Trends Discussion - The company will discuss overall market trends during the conference[5] Conference Webcast and Materials - A live audio webcast of the conference discussion, press release, and associated presentation will be available on Lilly's Investor website[5] - The presentation replay will be available on the website for approximately 30 days[5] Regulatory and Filing Information - The information in Item 2.02, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934[6] - Exhibit 99.1 is a press release of Eli Lilly and Company dated January 14, 2025[7] Executive Signatory - The report is signed by Lucas Montarce, Executive Vice President and Chief Financial Officer of Eli Lilly and Company[10]